Skip to content

Key takeaways:

  • Easing inflation and rate cuts create renewed tailwinds for quality growth—especially midcaps poised for earnings and multiple recovery.
  • Market leadership should broaden beyond mega-cap technology, lifting selected underappreciated European growth areas and undervalued health care innovators.
  • Artificial Intelligence’s (AI) next phase is shifting from infrastructure builders to integrators. Companies embedding AI into products and operations unlock new profit pools despite near-term volatility.
     

Setting the stage

The past several years have witnessed extraordinary technological and economic shifts. The proliferation of AI has transformed business models and driven investor enthusiasm, propelling a small group of dominant United States companies—most notably the “Magnificent Seven”—to outsized market leadership. In contrast, European equity markets, with their heavier weightings in financials and consumer sectors and lighter exposure to technology, have favored value-oriented segments.

However, as we approach 2026, the market environment continues to evolve. Trade policy uncertainty, geopolitical tensions, and supply-chain realignments have tested corporate resilience and investor confidence. Cost pressures remain elevated and businesses have been forced to adapt to a fragmented and dynamic operating environment. Yet, amid this complex backdrop, we remain focused on what has long defined our investment discipline: Owning high-quality growth companies with durable competitive advantages. This steadfast approach—research-driven, benchmark-agnostic, and risk-aware—continues to be our guide in pursuing sustainable alpha across cycles. As we look ahead to 2026, we see several reasons for optimism for active growth investors.

Discipline, quality, and long-term vision

Looking toward 2026, markets seem to be transitioning from a narrow, liquidity-driven regime to one shaped by fundamentals, innovation, and active management. For growth investors, this could be a welcome rebalancing. We believe the coming years will reward investors who can distinguish durable innovation from cyclical enthusiasm. Our team continues to invest on behalf of our clients with patience, discipline, and diligence—qualities that have defined our process for over two decades.

WHAT ARE THE RISKS?

All investments involve risks, including possible loss of principal. Past performance is not an indicator or a guarantee of future performance.

Equity securities are subject to price fluctuation and possible loss of principal.

Small- and mid-cap stocks involve greater risks and volatility than large-cap stocks.

Investment strategies which incorporate the identification of thematic investment opportunities, and their performance, may be negatively impacted if the investment manager does not correctly identify such opportunities or if the theme develops in an unexpected manner. Focusing investments in the health care, information technology (IT) and/or technology-related industries carries much greater risks of adverse developments and price movements in such industries than a strategy that invests in a wider variety of industries.

Any companies and/or case studies referenced herein are used solely for illustrative purposes; any investment may or may not be currently held by any portfolio advised by Franklin Templeton. The information provided is not a recommendation or individual investment advice for any particular security, strategy, or investment product and is not an indication of the trading intent of any Franklin Templeton managed portfolio.

WF: 7827359

Copyright ©2025. Franklin Templeton. All rights reserved.

This document is intended to be of general interest only. This document should not be construed as individual investment advice or offer or solicitation to buy, sell or hold any shares of fund. The information provided for any individual security mentioned is not a sufficient basis upon which to make an investment decision. Investments involves risks. Value of investments may go up as well as down and past performance is not an indicator or a guarantee of future performance. The investment returns are calculated on NAV to NAV basis, taking into account of reinvestments and capital gain or loss. The investment returns are denominated in stated currency, which may be a foreign currency other than USD and HKD (“other foreign currency”). US/HK dollar-based investors are therefore exposed to fluctuations in the US/HK dollar / other foreign currency exchange rate. Please refer to the offering documents for further details, including the risk factors.

The data, comments, opinions, estimates and other information contained herein may be subject to change without notice. There is no guarantee that an investment product will meet its objective and any forecasts expressed will be realized. Performance may also be affected by currency fluctuations. Reduced liquidity may have a negative impact on the price of the assets. Currency fluctuations may affect the value of overseas investments. Where an investment product invests in emerging markets, the risks can be greater than in developed markets. Where an investment product invests in derivative instruments, this entails specific risks that may increase the risk profile of the investment product. Where an investment product invests in a specific sector or geographical area, the returns may be more volatile than a more diversified investment product. Franklin Templeton accepts no liability whatsoever for any direct or indirect consequential loss arising from use of this document or any comment, opinion or estimate herein. This document may not be reproduced, distributed or published without prior written permission from Franklin Templeton.

Any share class with “(Hedged)” in its name will attempt to hedge the currency risk between the base currency of the Fund and the currency of the share class, although there can be no guarantee that it will be successful in doing so. In some cases, investors may be subject to additional risks.

Please contact your financial advisor if you are in doubt of any information contained herein.

For UCITS funds only: In addition, a summary of investor rights is available from here. The fund(s)/ sub-fund(s) are notified for marketing in various regions under the UCITS Directive. The fund(s)/ sub-fund(s) can terminate such notifications for any share class and/or sub-fund at any time by using the process contained in Article 93a of the UCITS Directive.

For AIFMD funds only: In addition, a summary of investor rights is available from here. The fund(s)/ sub-fund(s) are notified for marketing in various regions under the AIFMD Directive. The fund(s)/ sub-fund(s) can terminate such notifications for any share class and/or sub-fund at any time by using the process contained in Article 32a of the AIFMD Directive.

For the avoidance of doubt, if you make a decision to invest, you will be buying units/shares in the fund(s)/ sub-fund(s) and will not be investing directly in the underlying assets of the fund(s)/ sub-fund(s).

This document is issued by Franklin Templeton Investments (Asia) Limited and has not been reviewed by the Securities and Futures Commission of Hong Kong.

Unless stated otherwise, all information is as of the date stated above. Source: Franklin Templeton.

CFA® and Chartered Financial Analyst® are trademarks owned by CFA Institute.